GE
61
-3
AVGO
18
-9
GIS
22
-4
IRM
41
3
BEN
50
9
CNP
54
10
XYL
35
-2
AXP
67
-2
STZ
52
-6
SWK
50
-5
RHI
57
-6
URBN
48
-6
ORLY
60
-5
WYNN
36
-5
INTU
58
-3
AIV
64
4
CVS
41
-4
HRL
35
-3
MS
77
-2
DAL
84
-3
GE
61
-3
AVGO
18
-9
GIS
22
-4
IRM
41
3
BEN
50
9
CNP
54
10
XYL
35
-2
AXP
67
-2
STZ
52
-6
SWK
50
-5
RHI
57
-6
URBN
48
-6
ORLY
60
-5
WYNN
36
-5
INTU
58
-3
AIV
64
4
CVS
41
-4
HRL
35
-3
MS
77
-2
DAL
84
-3
Financhill
Back

Fidelity Investment Grade Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
16

FIGB
Fidelity Investment Grade Bd ETF

Last Price:
42.65
Seasonality Move:
1.06%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
16
Fidelity Investment Grade Bd ETF (FIGB) is a Sell

Is Fidelity Investment Grade Bd ETF a Buy, Sell or Hold?

  • The current Fidelity Investment Grade Bd ETF [FIGB] share price is $42.64. The Score for FIGB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • FIGB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FIGB Stock Price Chart

What is Fidelity Investment Grade Bd ETF's stock price today?

  • The Fidelity Investment Grade Bd ETF share price today is $42.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FIGB is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FIGB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 38.11 Sell
Chaikin Money Flow: 6896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.72 - 43.3) Sell
Bollinger Bands (100): (42.81 - 44.07) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FIGB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.77 Sell
20-day SMA: 42.9 Sell
50-day SMA: 43.56 Sell
200-day SMA: 42.91 Sell
8-day EMA: 42.75 Sell
20-day EMA: 42.94 Sell
50-day EMA: 43.26 Sell
200-day EMA: 43.07 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Fidelity Investment Grade Bd ETF Earnings Growth & FIGB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Fidelity Investment Grade Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):